Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...

After an inspiring appearance at the Vanity Fair Oscars after-party, Selma Blair is using the spotlight to bring attention to life with multiple sclerosis. RELATED: Selma Blair dons stunning, ...

Many people with multiple sclerosis struggle with balance and coordination, and this study uncovers a hidden reason why.

Nearly five months since revealing her multiple sclerosis diagnosis, Selma Blair is sharing her story. Just days after making her first public appearance since the announcement at the Oscars 2019 ...

Professional societies of neurologists, including most prominently the American Academy of Neurology (AAN) and the European Academy of Neurology (EAN) periodically release recommendations to guide ...

The CD40–CD40L costimulatory pathway regulates adaptive and innate immune responses and has been implicated in the pathogenesis of multiple sclerosis. Frexalimab is a second-generation anti-CD40L ...

An American neurologist and an Italian epidemiologist whose work revolutionized the treatment of multiple sclerosis have won ...

What Is Late-Onset Multiple Sclerosis? When you have multiple sclerosis (MS), your immune system attacks nerve cells and fibers called axons in your brain. When this happens, your brain can’t send ...

The Marburg variant of multiple sclerosis is extremely rare but also the most severe. Life expectancy has been weeks or months, but advances in treatment have led to an improved outlook. Multiple ...

Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...

Embed <iframe src="https://www.npr.org/player/embed/898856/898857" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player"> An ...